A new discovery can change the way heart attacks work



A new discovery can change the way heart attacks work

Heart attacks are extraordinary medical conditions that occur as a result of a break in blood flow to the heart, which is often caused by strokes. In Sweden, a new study has been conducted that highlights the discovery that may change the current guidelines on heart attacks.

Ig or Ig are known to be the type of protein produced by plasma cells in the blood. These antibodies often interact with the immune system and fight against a harmful foreign object.

Recently, researchers at the Karolen Institute in Solna, Sweden, found that some antibodies – associated with rheumatic diseases – are present in large numbers in people who have already had a heart attack.

These antibodies are antibodies against phospholipid-aPL, which are abnormal bodies that attack some body-generated tissues such as cardiolipin (lipoprotein) and beta-2-glycoprotein (plasma protein).

Scientists have found that these objects (aPLs) are usually seen in people with rheumatic diseases such as lupus and systemic lupus erythematosus.

They also noted that increasing their presence increases the risk of blood clots, such as phospholipid antibody syndrome – APS.

Antibodies are found in high levels

In the current study, scientists have seen the presence of alfalfa excessively in the body of many people who have already had a heart attack and were not infected with autoimmune diseases.

Researchers worked with 800 people from 17 Swedish hospitals who had a heart attack. To ensure the results, the same amount of healthy people were used for monitoring. Blood samples were analyzed twice, once after 6 weeks of infection and once every 10 weeks.

Scientists looked for three different types of aPL: immunoglobulin G, globulin M and globulin A.

In examining the data, 11% of participants had a high level of aPL, 10 times more than normal.

"I am convinced that antibodies are more common than we think and now I can analyze their presence," says Elisabet Svenungsson.

How can these results be changed from therapeutic guidelines?

Although the results showed that G-globulins were present at a high level in volunteers, they were at risk of stroke, but scientists realize that these results do not accurately reflect aPL levels and may be a one-off response to heart attacks.

However, if elevated aCL levels persist for 3 months, the patient is diagnosed with phospholipid antibody syndrome, resulting in increased blood clots.

Professor Svenungsson explains: "In this case, the patient is treated with warfarin for anticoagulants to reduce the risk of new blood clots."


الف Phospholipid: the type of fat is the basic component of the cell membrane.

الذ Lupus: Chronic inflammatory diseases caused by the immune system that attacks the cells of the body.

Systemic lupus erythematosus: An autoimmune disease that occurs due to damage to the immune system. This is called a name caused by a rash on the cheeks and the bridge.

متلازمة Syndrome of phospholipid antibodies: a blood clotting disorder that can lead to pregnancy-related complications such as abortion, pregnancy poisoning, or the birth of a dead child.


  • Translation: Shaima Mamdouh
  • Check: No patent
  • Edits: زيد أبو الرب

Source

Thank you for visiting our website today and if you have any questions about this message, a new discovery may change the way heart attacks are treated. Let us know or leave a comment below
Source: I believe


Source link